SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces
Investigation of White River Capital, Inc. (RVR), BioMimetic
Therapeutics Inc. (BMTI) , Jeffries Group, Inc. (JEF) and Provectus
Pharmaceuticals, Inc. (PVCT)
NEW YORK, Nov. 21, 2012 /PRNewswire/ --
(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO
)
White River Capital, Inc.
Levi & Korsinsky is
investigating the Board of Directors of White River Capital, Inc.
(NYSE MKT: RVR) for possible breaches of fiduciary duty and other
violations of state law in connection with the sale of the Company
and its subsidiary, Coastal Credit, LLC, to an affiliate of
Parthenon Capital Partners for $23
per share.
Click here to learn more about the investigation
http://zlk.9nl.com/white-river-capital-rvr.
BioMimetic Therapeutics Inc.
Levi & Korsinsky is
investigating the Board of Directors of BioMimetic Therapeutics
Inc. (NasdaqGS: BMTI) for possible breaches of fiduciary duty and
other violations of state law in connection with the sale of the
Company to Wright Medical Group Inc. (NasdaqGS: WMGI) under which
shareholders BioMimetic shareholders will receive $1.50 in cash and 0.2482 shares of Wright common
stock for each share of BioMimetic stock they own.
Click here to learn more about the investigation
http://zlk.9nl.com/biomimetic-bmti.
Jeffries Group, Inc.
Levi & Korsinsky is
investigating the Board of Directors of Jeffries Group, Inc. (NYSE:
JEF) for possible breaches of fiduciary duty and other violations
of state law in connection with the sale of the Company to its
largest shareholder, Leucadia National Corp. (NYSE: LUK) under
which shareholders will receive 0.81 Leucadia shares for each share
of Jefferies stock they own, representing an approximate value of
$17.24 per share. At least one
analyst set a price target of $19.00
per Jefferies share.
Click here to learn more about the investigation
http://zlk.9nl.com/jefferies-group-jef, or call:
877-363-5972.
Provectus Pharmaceuticals, Inc.
Levi & Korsinsky,
LLP is investigating Provectus Pharmaceuticals, Inc. (OTC BB:
PVCT), and its Board of Directors in connection with the
compensation provided to certain of its executive officers.
To get more information, click here:
http://zlk.9nl.com/provectus-pharmaceuticals-pvct, or call:
877-363-5972
Levi & Korsinsky is a national firm with offices in
New York and Washington D.C.
The firm has extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits.
Attorney advertising. Prior results do not guarantee similar
outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
SOURCE Levi & Korsinsky, LLP